Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Thongprasert

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|August 10, 2000
Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter studyS Thongprasert, S Maoleekoonpairoj, S Laohavinij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinomaS Thongprasert, S Napapan, C Charoentum, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 9, 2001
Protective effects of fosfomycin on cisplatin-induced nephrotoxicity in patients with lung cancerN Rojanasthien, B Kumsorn, B Atikachai, et al.
The American Journal of Medicine|October 30, 1984
Systemic candidiasis in cancer patientsA W Maksymiuk, S Thongprasert, R Hopfer, et al.
Cancer|December 5, 1998
Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study GroupD T Chua, J S Sham, D Choy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancerT S Mok, S L Geater, N Iannotti, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|August 10, 2000
Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter studyS Thongprasert, S Maoleekoonpairoj, S Laohavinij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinomaS Thongprasert, S Napapan, C Charoentum, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 9, 2001
Protective effects of fosfomycin on cisplatin-induced nephrotoxicity in patients with lung cancerN Rojanasthien, B Kumsorn, B Atikachai, et al.
The American Journal of Medicine|October 30, 1984
Systemic candidiasis in cancer patientsA W Maksymiuk, S Thongprasert, R Hopfer, et al.
Cancer|December 5, 1998
Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study GroupD T Chua, J S Sham, D Choy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancerT S Mok, S L Geater, N Iannotti, et al.
Pageof 2